1 / 23

Paige A. Green, PhD, MPH

Federally Funded Research and Development Center/Frederick National Laboratory for Cancer Research and the Division of Cancer Control and Population Sciences. Paige A. Green, PhD, MPH. DCCPS Mission and Vision.

roughton
Download Presentation

Paige A. Green, PhD, MPH

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Federally Funded Research and Development Center/Frederick National Laboratory for Cancer Research and the Division of Cancer Control and Population Sciences Paige A. Green, PhD, MPH

  2. DCCPS Mission and Vision • Aims to reduce risk, incidence, and deaths from cancer, and enhance quality of life for cancer survivors • Evaluate what has been learned, identify new priorities/strategies, and effectively apply research discoveries to reduce cancer burden • Aspires to be the national model for cancer control science • Cross-cutting areas of emphasis: energy balance, health disparities, patient-centered communication and care coordination, patterns of care

  3. DCCPS Organization

  4. DCCPS Extramural Research Initiatives Supported by FFRDC/FNLCR • NCI Network on Biobehavioral Pathways in Cancer • Affective Science and Palliative Care Pilot Program • Systematic Review to Inform Research and Treatment of Multi-morbidities • N of 1 Trial Design for Behavioral Oncology • Evidence Synthesis for the Clinically Relevant Variant Consortium

  5. The National Cancer InstituteNetwork on Biobehavioral Pathways in Cancer

  6. NCI Network on Biobehavioral Pathways in Cancer • Accelerate the discovery of cancer-relevant molecular pathways and networks regulated by social, behavioral, or psychological factors • Support collaborative engagement and meritorious proof of concept/feasibility projects

  7. NCI Network on Biobehavioral Pathways in Cancer • Based on a fully collaborative model between the FFRDC contractor, Academia, International Partners, and Consultants • See details of partnerships in the following slides, and note that each collaboration includes the involvement and coordination of the FFRDC contractor

  8. Network Projects Supported by FFRDC/FNLCR • Novel Small Scale Pilot Projects to Advance the Mission of the NCI Network on Biobehavioral Pathways in Cancer • Perioperative Use of Beta-Blocker and COX2 Inhibitor • fMRI Probe Optimization Study of Social Support • Stress and Tumorigenesis in Normal and p53 Knockout Models

  9. Small-Scale Pilot Projects to Advance the Mission of the NCI Network on Biobehavioral Pathways in Cancer • Advance knowledge of the molecular and signaling pathways linking psychological, behavioral, or social factors to cancer biology • Use that knowledge to seed development of efficacious interventions to improve clinical outcomes

  10. Perioperative Use of Beta-blocker and Cox2 Inhibitor • Randomized prospective phase II pilot study to assess the short-term effects of counteracting excess perioperative catecholamine and prostaglandin levels in patients undergoing breast cancer surgery • Institution • Tel Aviv University • Principal Investigator • Shamgar Ben-Eliyahu

  11. fMRI Probe Optimization Study of Social Support • Identify and pilot test fMRI probe tasks that can be used to capture systematic individual differences in neural activity based on measured experiences of social support • Institution • University of California, Los Angeles • Principal Investigator • Naomi Eisenberger

  12. Stress and Tumorigenesis in Normal and p53 Knockout Models • Test whether use of an established restraint stress paradigm results in an accumulation of DNA damage, as determined by sequencing of DNA and DNA copy number analysis of cells • Institution • Rutgers Robert Wood Johnson Medical School • Principal Investigator • WenweiHu

  13. Affective Science and Palliative Care Pilot Program

  14. Affective Science and Palliative Care Pilot Projects • Reanalyze data from palliative care trials to generate hypotheses about mechanisms of effects from a basic affective or decision science perspective • Insert measures or methodology into existing or planned palliative care trials to generate hypotheses about mechanisms of effects from a basic affective or decision science perspective

  15. Systematic Review to Inform Research and Treatment of Multi-morbidities

  16. Systematic Review to Inform Research and Treatment of Multi-morbidities • Review, evaluate and summarize data on the representation of individuals with multiple chronic conditions in randomized controlled trials of behavioral and psychosocial interventions • Institution • Washington University in St. Louis • Principal Investigator • Graham Colditz

  17. N of 1 Trial Design in Behavioral Oncology

  18. N of 1 Trial Design for Behavioral and Psychological Issues in Cancer Survivorship • N of 1 protocol development for depression symptom management among cancer survivors with multi-morbidity • Institution • Columbia University • Principal Investigator • Karina Davidson

  19. Evidence Synthesis for the Clinically Relevant Variant Consortium

  20. ClinGen – Clinical Genome Resource

  21. Evidence Synthesis for the Clinically Relevant Variant Consortium • Refine methodology, produce evidence-based reports for ClinGen, and coordinate with the other ClinGengroups • Institution • Kaiser Permanente Northwest • Principal Investigator • Katrina Goddard

  22. DCCPS Extramural Research Initiatives Supported by FFRDC/FNLCR • NCI Network on Biobehavioral Pathways in Cancer • Affective Science and Palliative Care Pilot Program • Systematic Review to Inform Research and Treatment of Multi-morbidities • N of 1 Trial Design for Behavioral Oncology • Evidence Synthesis for the Clinically Relevant Variant Consortium

More Related